Skip to main content
. Author manuscript; available in PMC: 2019 Jul 25.
Published in final edited form as: Surgery. 2018 May 8;164(2):333–343. doi: 10.1016/j.surg.2018.03.020

Fig 3.

Fig 3.

Estimated blood loss based on operative approach and pre-treatment with neoadjuvant chemotherapy. (A) Estimated blood loss (EBL) based on resection approach. (B) Differences in EBL between upfront resection or after neoadjuvant chemotherapy for each operative approach. Boxes represent interquartile range (IQR) with whiskers spanning to 1.5*IQR. Horizontal line within box represents median. Dots represent values outside of 1.5*IQR. Significance (P values) assessed by Kruskal-Wallis test and Wilcoxon rank sum test.